Structures by: Ibrar A.
Total: 19
C11H14O4
C11H14O4
Crystals (2012) 2, 2 521-527
a=8.5518(3)Å b=10.8826(8)Å c=11.9939(6)Å
α=101.273(5)° β=98.287(3)° γ=94.092(4)°
Aminonitroguanidinium bromide monohydrate
CH6N5O2,Br,H2O
Crystals (2012) 2, 2 675-689
a=8.0261(5)Å b=12.7412(7)Å c=7.9296(5)Å
α=90.00° β=118.051(9)° γ=90.00°
(E)-N'-(2-(allyloxy)benzylidene)-2-(4-bromophenyl)acetohydrazide
C18H17BrN2O2
RSC Advances (2015) 5, 110 90806
a=14.6957(3)Å b=4.84494(11)Å c=23.1542(5)Å
α=90° β=102.219(2)° γ=90°
E)-N'-(biphenyl-4-ylmethylene)-2-(4-bromophenyl)acetohydrazide
C21H17BrN2O
RSC Advances (2015) 5, 110 90806
a=20.4423(11)Å b=5.5758(3)Å c=7.6350(7)Å
α=90° β=98.621(7)° γ=90°
5-(2,6-dichlorobenzyl)-1,3,4-oxadiazole-2(3H)-thione, dimethyl sulfoxide solvate
C9H6Cl2N2OS,C2H6OS
CrystEngComm (2017)
a=11.9557(4)Å b=13.5378(5)Å c=9.0424(3)Å
α=90° β=99.981(2)° γ=90°
C9H7ClN2OS
C9H7ClN2OS
CrystEngComm (2017)
a=12.7860(5)Å b=12.8784(5)Å c=13.3520(6)Å
α=90° β=116.878(2)° γ=90°
C9H7BrN2OS
C9H7BrN2OS
CrystEngComm (2017)
a=4.7154(4)Å b=11.7528(9)Å c=17.8887(16)Å
α=90° β=90.015(4)° γ=90°
C17H13BrN4OS
C17H13BrN4OS
RSC Adv. (2015)
a=7.5733(3)Å b=10.0581(7)Å c=11.2828(6)Å
α=105.441(5)° β=102.930(4)° γ=91.660(4)°
5-(4-methoxybenzyl)-1,3,4-thiadiazole-2(3H)-thione
C10H10N2O2S
CrystEngComm (2014) 16, 2 164
a=7.5365(3)Å b=5.5019(3)Å c=24.9737(12)Å
α=90° β=92.956(2)° γ=90°
5-(2-methoxybenzyl)-1,3,4-thiadiazole-2(3H)-thione
C10H10N2O2S
CrystEngComm (2014) 16, 2 164
a=11.6420(9)Å b=4.6349(4)Å c=18.8292(18)Å
α=90.00° β=95.453(5)° γ=90.00°
5-(3-methoxybenzyl)-1,3,4-thiadiazole-2(3H)-thione
C10H10N2O2S
CrystEngComm (2014) 16, 2 164
a=8.6916(7)Å b=13.2144(11)Å c=8.9458(7)Å
α=90.00° β=93.960(4)° γ=90.00°
5-(2-methoxyphenethyl)-1,3,4-thiadiazole-2(3H)-thione
C11H12N2O2S
CrystEngComm (2014) 16, 2 164
a=9.8668(8)Å b=6.9888(6)Å c=16.1978(13)Å
α=90.00° β=98.855(4)° γ=90.00°
5-(4-methoxyphenethyl)-1,3,4-thiadiazole-2(3H)-thione
C11H12N2O2S
CrystEngComm (2014) 16, 2 164
a=7.8075(8)Å b=11.2905(13)Å c=13.2898(18)Å
α=88.359(7)° β=80.741(6)° γ=73.514(6)°
2-(4-Chlorophenyl)-2-oxoethyl 3-bromobenzoate
C15H10BrClO3
Acta Crystallographica Section E (2014) 70, 11 301-304
a=6.6797(3)Å b=10.0238(4)Å c=10.7851(5)Å
α=90.980(4)° β=107.573(4)° γ=92.138(3)°
<i>N</i>-(3-Bromophenyl)-3,4,5-trimethoxybenzamide
C16H16BrNO4
Acta Crystallographica Section E (2009) 65, 7 o1470
a=13.3085(8)Å b=4.9953(3)Å c=23.4061(12)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-oxo-2<i>H</i>-chromene-3-carboxylate
C11H8O4
Acta Crystallographica Section E (2012) 68, 10 o3024
a=3.8874(10)Å b=9.782(3)Å c=13.078(3)Å
α=111.569(19)° β=90.83(2)° γ=95.01(2)°
2-(4-Methylphenyl)-2-oxoethyl 3-bromobenzoate
C16H13BrO3
Acta Crystallographica Section E (2012) 68, 12 o3465
a=4.7977(3)Å b=10.9951(7)Å c=14.1645(8)Å
α=74.829(5)° β=87.758(5)° γ=79.327(5)°